Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI Study

Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients

(2023) Lei Tian et al.   JAMA Ophthalmology

Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape

(2023) John D. Sheppard et al.   Ophthalmology and Therapy

NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study

(2023) John D. Sheppard et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Metabolomics and lipidomics approaches in human tears: A systematic review

(2022) Raoul K Khanna et al.   SURVEY OF OPHTHALMOLOGY

Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment

(2022) Gerd Geerling et al.   Ophthalmology and Therapy

NOV03 for Dry Eye Disease Associated With Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study

(2022) Joseph Tauber et al.   OPHTHALMOLOGY

Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease

(2021) David Wirta et al.   OPHTHALMOLOGY

Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial

(2020) Doreen Schmidl et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease

(2020) Joseph Tauber et al.   CORNEA

Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics

(2019) Priyanka Agarwal et al.   Ocular Surface

Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review

(2019) Edward J. Holland et al.   Ocular Surface

A Review on Evidence-Based Treatments for Meibomian Gland Dysfunction

(2019) Pun Yuet Lam et al.   Eye & Contact Lens-Science and Clinical Practice

One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease

(2017) Christophe Baudouin et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

TFOS DEWS II pathophysiology report

(2017) Anthony J. Bron et al.   Ocular Surface

TFOS DEWS II Management and Therapy Report

(2017) Lyndon Jones et al.   Ocular Surface

TFOS DEWS II Definition and Classification Report

(2017) Jennifer P. Craig et al.   Ocular Surface

Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up

(2016) Morgane Straub et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction

(2016) Christophe Baudouin et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review

(2016) Marguerite McDonald et al.   Ocular Surface

Distribution of Aqueous-Deficient and Evaporative Dry Eye in a Clinic-Based Patient Cohort

(2012) Michael A. Lemp et al.   CORNEA